Genome Analysis Across Populations in Inflammatory Bowel Disease
Recruiting · NCT06042387 · Observational (researchers observe without assigning treatment) · Lead sponsor: Mount Sinai Hospital, Canada
View the official record on ClinicalTrials.gov →Interventions studied
Blood or saliva sample collection
What this trial is about
Objective: To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Subjects: diagnosed with Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis, IBD-undetermined)
- Available medical records to confirm IBD diagnosis (Crohn's disease, Ulcerative colitis, IBD undetermined (IBD-U))
- Healthy controls: no personal history of IBD, no family history of IBD, no history of unexplained chronic diarrhea/blood in stool/anemia/abdominal pain/weight loss
- Any age
Exclusion criteria
- \- Subjects with other gastrointestinal conditions not meeting the above IBD or Healthy Control criteria
Where it is running
2 locations listed.
- Sinai Health System - Toronto, Ontario, Canada
- Sinai Health System - Toronto, Ontario, Canada